Filing Details

Accession Number:
0001209191-10-025610
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-05-06 13:00:00
Reporting Period:
2010-05-04
Filing Date:
2010-05-06
Accepted Time:
2010-05-06 06:51:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1130166 Cyclacel Pharmaceuticals Inc. CYCC Pharmaceutical Preparations (2834) 911766850
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1450497 Edward Robert Sosnowski 200 Connell Drive, Suite 1500
Berkeley Heights NJ 07922
Vp, Sales & Marketing No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Per Share Acquisiton 2010-05-04 10,000 $0.44 10,000 No 4 M Direct
Common Stock, $0.001 Par Value Per Share Disposition 2010-05-04 10,000 $2.50 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option Disposition 2010-05-04 10,000 $0.00 10,000 $0.44
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
90,000 2009-11-18 2018-11-18 No 4 M Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by Mr. Sosnowski.
  2. These securities were issued as part of the Issuer's annual equity compensation to executive officers on November 18, 2008.
  3. 23,333 of these options vested on November 18, 2009, the first anniversary of the grant date, and the balance of the options vest ratably on a monthly basis over the following 24 months.